Ledger.Open graph →
SEC Form D · filed May 6, 2024

Atacama Therapeutics, Inc

Offering
$4.7M
Sold
$830K
Exemption
Rule 506(b)
Industry
Other Health Care
Location
WELLESLEY, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Jonathan Reis · Wellesley, MADirectorJoseph Baron · Wellesley, MAExec · DirectorDavid Dove · Wellesley, MADirectorJoseph Baron · Wellesley, MAExec · DirectorJonathan Reis · Wellesley, MADirectorLarry A. Pierce · Edmonds, WAExec · DirectorNick Seaver · Watertown, MADirectorDavid Dove · Wellesley, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗